Literature DB >> 12934669

Antagonism of croton oil inflammation by topical emu oil in CD-1 mice.

Subbiah Yoganathan1, Robert Nicolosi, Thomas Wilson, Garry Handelman, Patrick Scollin, Richard Tao, Paul Binford, Frank Orthoefer.   

Abstract

Emu oil is derived from the emu (Dromaius novaehollandiae), which originated in Australia, and has been reported to have anti-inflammatory properties. Inflammation was induced in anesthetized CD-1 mice by applying 50 microL of 2% croton oil to the inner surface of the left ear. After 2 h, the area was treated with 5 microL of emu, fish, flaxseed, olive, or liquified chicken fat, or left untreated. Animals were euthanized at 6 h postapplication of different oils, and earplugs (EP) and plasma samples were collected. Inflammation was evaluated by change in earlobe thickness, increase in weight of EP tissue (compared to the untreated ear), and induction in cytokines interleukin (IL)-1alpha and tumor necrosis factor-alpha (TNF-alpha) in EP homogenates. Although reductions relative to control (croton oil) were noted for all treatments, auricular thickness and EP weights were significantly reduced (-72 and -71%, respectively) only in the emu oil-treated group. IL-1alpha levels in homogenates of auricular tissue were significantly reduced in the fish oil (-57%) and emu oil (-70%) groups relative to the control group. The cytokine TNF-alpha from auricular homogenates was significantly reduced in the olive oil (-52%) and emu oil (-60%) treatment groups relative to the control group. Plasma cytokine levels were not changed by croton oil treatment. Although auricular thickness and weight were significantly correlated with each other (r = 0.780, P < 0.003), auricular thickness but not weight was significantly correlated with cytokine IL-alpha (r = 0.750, P < 0.006) and TNF-alpha (r = 0.690, P < 0.02). These studies indicate that topical emu oil has anti-inflammatory properties in the CD-1 mouse that are associated with decreased auricular thickness and weight, and with the cytokines IL-1alpha and TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934669     DOI: 10.1007/s11745-003-1104-y

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  26 in total

1.  Effect of emu oil on auricular inflammation induced with croton oil in mice.

Authors:  A López; D E Sims; R F Ablett; R E Skinner; L W Léger; C M Lariviere; L A Jamieson; J Martínez-Burnes; G G Zawadzka
Journal:  Am J Vet Res       Date:  1999-12       Impact factor: 1.156

2.  Preventive effect of hesperidin against inflammation in CD-1 mouse skin caused by tumor promoter.

Authors:  H Koyuncu; B Berkarda; F Baykut; G Soybir; C Alatli; H Gül; M Altun
Journal:  Anticancer Res       Date:  1999 Jul-Aug       Impact factor: 2.480

3.  B-Cell deficiency predisposes mice to disseminating anaerobic infections: protection by passive antibody transfer.

Authors:  L Hou; H Sasakj; P Stashenko
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  The croton oil ear test revisited.

Authors:  A Tubaro; P Dri; G Delbello; C Zilli; R Della Loggia
Journal:  Agents Actions       Date:  1986-01

5.  Role of the maternal acute phase response and tumor necrosis factor alpha in the developmental toxicity of lipopolysaccharide in the CD-1 mouse.

Authors:  Tyra M Leazer; Brenda Barbee; Marian Ebron-McCoy; Gerelyn A Henry-Sam; John M Rogers
Journal:  Reprod Toxicol       Date:  2002 Mar-Apr       Impact factor: 3.143

6.  Protective effect of desferrioxamin against TPA caused inflammation in CD-1 mouse skin.

Authors:  G R Soybir; H Koyuncu; F Köksoy; O Yalçin; A Ozşeker; C Alatli; C Topuzlu
Journal:  Surg Oncol       Date:  1996 Oct-Dec       Impact factor: 3.279

7.  Promotion of second intention wound healing by emu oil lotion: comparative results with furasin, polysporin, and cortisone.

Authors:  M J Politis; A Dmytrowich
Journal:  Plast Reconstr Surg       Date:  1998-12       Impact factor: 4.730

8.  Effects of specific fatty acids (8:0, 14:0, cis-18:1, trans-18:1) on plasma lipoproteins, early atherogenic potential, and LDL oxidative properties in the hamster.

Authors:  R J Nicolosi; T A Wilson; E J Rogers; D Kritchevsky
Journal:  J Lipid Res       Date:  1998-10       Impact factor: 5.922

9.  Anti-inflammatory activity of emu oils in rats.

Authors:  J M Snowden; M W Whitehouse
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 4.473

10.  Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine.

Authors:  M W Whitehouse; A G Turner; C K Davis; M S Roberts
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 5.093

View more
  18 in total

1.  Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.

Authors:  Suzanne M Abimosleh; Ruth J Lindsay; Ross N Butler; Adrian G Cummins; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study.

Authors:  J Twidwell; L Levine
Journal:  Int J Impot Res       Date:  2015-12-24       Impact factor: 2.896

3.  Improvement of bioavailability and anti-inflammatory potential of curcumin in combination with emu oil.

Authors:  Manish Kumar Jeengar; Shweta Shrivastava; Kala Nair; Sreenivasa Reddy Singareddy; Uday Kumar Putcha; M V N Kumar Talluri; V G M Naidu; Ramakrishna Sistla
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

4.  Orally administered emu oil attenuates disease in a mouse model of Crohn's-like colitis.

Authors:  Chloe J Mitchell; Gordon S Howarth; Lauren C Chartier; Debbie Trinder; Ian C Lawrance; Li San Huang; Suzanne Mashtoub
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-09

5.  Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).

Authors:  Arlene Chan; R De Boer; A Gan; P Willsher; R Martin; Y Zissiadis; K Miller; A Bauwens; D Hastrich
Journal:  Support Care Cancer       Date:  2017-07-09       Impact factor: 3.603

6.  Development and characterization of ten novel microsatellite loci for the emu (Dromaius novaehollandiae) and genetic diversity of Japanese farm populations.

Authors:  Yuichi Koshiishi; Michiko Murata-Okubo; Shin-Ichiro Fujisawa; Gaku Shimoi; Hiroki Hirayama; Yuichi Kameyama; Kousaku Souma; Kenta Wada
Journal:  Mol Biol Rep       Date:  2020-02-21       Impact factor: 2.316

7.  Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer.

Authors:  Lauren C Chartier; Gordon S Howarth; Ian C Lawrance; Debbie Trinder; Scott J Barker; Suzanne Mashtoub
Journal:  Dig Dis Sci       Date:  2017-12-06       Impact factor: 3.199

8.  Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid.

Authors:  Kazuyuki Kitatani; Kely Sheldon; Viviana Anelli; Russell W Jenkins; Ying Sun; Gregory A Grabowski; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

9.  Ratite oils promote keratinocyte cell growth and inhibit leukocyte activation.

Authors:  Darin C Bennett; Gigi Leung; Eddy Wang; Sam Ma; Blanche K K Lo; Kevin J McElwee; Kimberly M Cheng
Journal:  Poult Sci       Date:  2015-07-27       Impact factor: 3.352

10.  The emu oil emulsified in egg lecithin and butylated hydroxytoluene enhanced the proliferation, stemness gene expression, and in vitro wound healing of adipose-derived stem cells.

Authors:  Khatereh Saei Arezoumand; Effat Alizadeh; Mohammad Esmaeillou; Maryam Ghasemi; Shahriar Alipour; Younes Pilehvar-Soltanahmadi; Nosratollah Zarghami
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-01-29       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.